In fact, IL-33 has proposed to hold anti-inflammatory and protective functions in AD (20–22) and IL-10, which can be also induced by IL-33 itself, exerts anti-inflammatory actions and was suggested to negatively regulate amyloid pathology in AD-like conditions (34, 35). This evidence concerns the gene IL10 and amyloidosis.